Alessandra Maciel Almeida
Overview
Explore the profile of Alessandra Maciel Almeida including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
251
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marques G, Almeida A, Gomes I, Silva M, Rezende B
Rev Bras Enferm
. 2023 Jul;
76(3):e20220486.
PMID: 37436234
Objectives: to identify whether implementing a supplementary Primary Health Care (PHC) system makes it possible to reduce care costs for older adults with heart diseases. Methods: a retrospective cohort of...
2.
da Silva M, Dos Santos J, Kakehasi A, Almeida A, Pimenta P, Alvares-Teodoro J, et al.
Sao Paulo Med J
. 2022 Aug;
140(6):787-797.
PMID: 36043662
Background: Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects multiple joints. It is associated with psoriasis and treated with synthetic and biologic drugs. Objective: The objective of this...
3.
Souza E, da Silva M, Dos Santos J, Reis E, Alvares-Teodoro J, de Assis Acurcio F, et al.
Einstein (Sao Paulo)
. 2022 Apr;
20:eAO6453.
PMID: 35416831
Objective: To evaluate the therapeutic response (functionality) and its associated factors in patients on biological drugs on the Public Health System for treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing...
4.
Chaves D, Bastos A, Almeida A, Guerra M, Teixeira M, Melo A, et al.
Rev Soc Bras Med Trop
. 2022 Feb;
55(suppl 1):e0271.
PMID: 35107529
Introduction: Pancreatic cancer is increasing worldwide. The burden of pancreatic cancer in Brazil and its states was analyzed and compared with that from the USA and China. Methods: This is...
5.
de Figueiredo L, Junior A, de Assis Acurcio F, Almeida A, Cherchiglia M, Wainstein A, et al.
Sci Rep
. 2021 Nov;
11(1):22501.
PMID: 34795383
Little is known about soft tissue sarcomas (STS) in Brazil, once the federal statistics regarding estimates on incidence and mortality of the most common cancers that affect the Brazilian population...
6.
Rocha W, Teodoro J, de Assis Acurcio F, Guerra Jr A, Moura I, Godman B, et al.
J Comp Eff Res
. 2021 Mar;
10(6):519-532.
PMID: 33739138
To evaluate the influence of organizational structure and technical-management activities on the availability of essential medicines in the primary healthcare. Cross-sectional, exploratory and evaluative study. The availability was evaluated according...
7.
da Silva M, Dos Santos J, Almeida A, Alvares-Teodoro J, de Assis Acurcio F
Expert Rev Pharmacoecon Outcomes Res
. 2021 Jan;
22(3):473-479.
PMID: 33474995
Background: TNF inhibitors are costly drugs supplied generally on health systems or private insurances. Performance analysis is essential to verify the results achieved by health technologies in these systems. The...
8.
Dos Santos J, da Silva M, Kakehasi A, Acurcio F, Almeida A, de Oliveira Junior H, et al.
Expert Rev Clin Immunol
. 2020 Nov;
16(12):1217-1225.
PMID: 33203248
: This study aims to evaluate and compare the use of subcutaneous anti-TNF for RA in a Brazilian real-life setting. : A prospective cohort of biological disease-modifying antirheumatic drug (bDMARD)-naïve...
9.
Moreira I, Bianchini M, Moreira G, Almeida A, Rezende B
BMC Womens Health
. 2020 Oct;
20(1):240.
PMID: 33109159
Background: Female sexual dysfunction is a common condition that negatively impacts the emotional health and quality of life of the affected individuals. Long-acting reversible contraceptives (LARCs) are becoming increasingly popular...
10.
Dos Santos J, da Silva M, Almeida A, de Assis Acurcio F, Alvares-Teodoro J
Expert Rev Pharmacoecon Outcomes Res
. 2020 Oct;
21(5):1011-1016.
PMID: 33086882
Background: Spending on drugs provided by the Brazilian Public Health System (BPHS) for the treatment of rheumatoid arthritis (RA) increased substantially with the beginning of the supply of biological disease-modifying...